Literature DB >> 31720864

Sleep Disorders in Wilson's Disease.

Valérie Cochen De Cock1,2, France Woimant3,4, Aurélia Poujois3,5.   

Abstract

PURPOSE OF REVIEW: We aimed to review the sleep disorders described in Wilson's disease (WD), focusing on their mechanisms and treatments. RECENT
FINDINGS: REM sleep behavior disorder or sleepiness can be warning signs of future WD. These early symptoms may significantly reduce the time to WD diagnosis. Early anti-copper therapies (chelators or zinc salts), reducing copper accumulation in the brain and though saving brain tissue, can allow the complete disappearance of these sleep disorders and of course improve the other symptoms of WD. Insomnia, restless legs syndrome (RLS), daytime sleepiness, cataplexy, and REM sleep behavior disorder (RBD) are present in WD and should be explored with video polysomnography and multiple sleep latency test. Suggested immobilization test could be useful in the diagnosis of RLS in WD. Motor and non-motor symptoms, dysautonomic dysfunctions, drugs, and lesions of the circuits regulating wake and sleep may be involved in the mechanisms of these sleep abnormalities. Adapted treatments should be proposed.

Entities:  

Keywords:  Cataplexy; Insomnia; REM sleep behavior disorder; Restless legs syndrome; Sleepiness; Wilson’s disease

Mesh:

Year:  2019        PMID: 31720864     DOI: 10.1007/s11910-019-1001-4

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  45 in total

Review 1.  Sleep disorders in chronic liver disease.

Authors:  Sharon De Cruz; Joseph Roland D Espiritu; Michelle Zeidler; Tisha S Wang
Journal:  Semin Respir Crit Care Med       Date:  2012-03-23       Impact factor: 3.119

Review 2.  Metabolism and functions of copper in brain.

Authors:  Ivo F Scheiber; Julian F B Mercer; Ralf Dringen
Journal:  Prog Neurobiol       Date:  2014-01-17       Impact factor: 11.685

3.  Wilson's disease. Psychiatric symptoms in 195 cases.

Authors:  T R Dening; G E Berrios
Journal:  Arch Gen Psychiatry       Date:  1989-12

4.  Liver Transplantation in Wilson's Disease with Neurological Impairment: Evaluation in 4 Patients.

Authors:  Chloé Laurencin; Anne Sophie Brunet; Jérôme Dumortier; Laurence Lion-Francois; Stéphane Thobois; Jean Yves Mabrut; Rémi Dubois; France Woimant; Aurélia Poujois; Olivier Guillaud; Alain Lachaux; Emmanuel Broussolle
Journal:  Eur Neurol       Date:  2016-11-19       Impact factor: 1.710

5.  Long term results of liver transplantation for Wilson's disease: experience in France.

Authors:  Olivier Guillaud; Jérôme Dumortier; Rodolphe Sobesky; Dominique Debray; Philippe Wolf; Claire Vanlemmens; François Durand; Yvon Calmus; Christophe Duvoux; Sébastien Dharancy; Nassim Kamar; Karim Boudjema; Pierre Henri Bernard; Georges-Philippe Pageaux; Ephrem Salamé; Jean Gugenheim; Alain Lachaux; Dalila Habes; Sylvie Radenne; Jean Hardwigsen; Olivier Chazouillères; Jean-Marc Trocello; France Woimant; Philippe Ichai; Sophie Branchereau; Olivier Soubrane; Denis Castaing; Emmanuel Jacquemin; Didier Samuel; Jean-Charles Duclos-Vallée
Journal:  J Hepatol       Date:  2013-11-06       Impact factor: 25.083

Review 6.  Wilson disease: brain pathology.

Authors:  Aurélia Poujois; Jacqueline Mikol; France Woimant
Journal:  Handb Clin Neurol       Date:  2017

Review 7.  Symptomatic treatment of neurologic symptoms in Wilson disease.

Authors:  Tomasz Litwin; Petr Dušek; Anna Członkowska
Journal:  Handb Clin Neurol       Date:  2017

8.  The spectrum of psychiatric symptoms in Wilson's disease: treatment and prognostic considerations.

Authors:  Paula C Zimbrean; Michael L Schilsky
Journal:  Am J Psychiatry       Date:  2015-11-01       Impact factor: 18.112

Review 9.  Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).

Authors:  Christopher J Earley; James Connor; Diego Garcia-Borreguero; Peter Jenner; John Winkelman; Phyllis C Zee; Richard Allen
Journal:  Sleep Med       Date:  2014-06-16       Impact factor: 3.492

10.  Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome.

Authors:  James R Connor; Xin-Sheng Wang; Richard P Allen; John L Beard; Jason A Wiesinger; Barbara T Felt; Christopher J Earley
Journal:  Brain       Date:  2009-05-25       Impact factor: 13.501

View more
  1 in total

Review 1.  The Role of Zinc in the Treatment of Wilson's Disease.

Authors:  Abolfazl Avan; Anna Członkowska; Susan Gaskin; Alberto Granzotto; Stefano L Sensi; Tjaard U Hoogenraad
Journal:  Int J Mol Sci       Date:  2022-08-18       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.